The global biosurgery market size is anticipated to reach USD 35.85 billion by 2030. The market is projected to grow at a CAGR of 4.7% from 2024 to 2030. Factors such as the availability of multifunctional products and increasing number of surgeries due to prevalence of lifestyle related disease, obesity, and sports related injuries are projected to drive the growth. Biosurgery products are used in surgical procedures for adhesion or wound sealing and healing damaged bones and tissues.
Biosurgery products are used for the treatment of chronic wounds, such as burns, foot ulcer, malignant wounds, and infected surgical wounds. Furthermore, increasing incidence of blood clotting among patients prone to excessive blood loss is expected to drive the market growth. Moreover, rising need for blood loss management and various severe trauma injuries is expected to drive the growth of biosurgery market over the forecast period.
High prevalence of diabetes increases the risk of wounds and infections, creating requirement for biosurgery products. According to the American College of Physicians, the global annual incidence of diabetic foot ulcer was 6.3% in 2017. This factor is projected to drive the product demand in the forthcoming years. Moreover, rising geriatric population prone to various chronic diseases is expected to propel the market. According to the World Health Organization (WHO), the global aging population is expected to reach 2 billion by 2050, from 900 million in 2015. Application of biosurgery in other surgical procedures, such as orthopedic, neurological, and gynecology surgeries is expected to drive the market.
This product will be delivered within 1-3 business days.
Biosurgery products are used for the treatment of chronic wounds, such as burns, foot ulcer, malignant wounds, and infected surgical wounds. Furthermore, increasing incidence of blood clotting among patients prone to excessive blood loss is expected to drive the market growth. Moreover, rising need for blood loss management and various severe trauma injuries is expected to drive the growth of biosurgery market over the forecast period.
High prevalence of diabetes increases the risk of wounds and infections, creating requirement for biosurgery products. According to the American College of Physicians, the global annual incidence of diabetic foot ulcer was 6.3% in 2017. This factor is projected to drive the product demand in the forthcoming years. Moreover, rising geriatric population prone to various chronic diseases is expected to propel the market. According to the World Health Organization (WHO), the global aging population is expected to reach 2 billion by 2050, from 900 million in 2015. Application of biosurgery in other surgical procedures, such as orthopedic, neurological, and gynecology surgeries is expected to drive the market.
Biosurgery Market Report Highlights
- Surgical sealants dominated the biosurgery market with a revenue share of 26.9% in 2023. The growth of this segment is primarily influenced by the growing number of surgeries performed for various reasons.
- The general surgery application segment dominated the global industry for biosurgery in 2023 and the cardiovascular surgery application segment is expected to experience the fastest CAGR from 2024 to 2030.
- North America biosurgery market dominated the global industry and accounted for the largest revenue share of 50.1% in 2023.
- The Asia-Pacific biosurgery market is anticipated to witness the fastest CAGR of 6.0% during the forecast period. The projected growth rate is attributed to rapid economic growth in countries such as China and India, increasing disposable income levels, and rising healthcare infrastructure.
The leading players in the Biosurgery market include:
- Sanofi
- Baxter
- INTEGRA LIFESCIENCES
- Medtronic
- B. Braun SE
- Pfizer Inc
- Stryker
- Johnson & Johnson Services, Inc
- BD
- Artivion, Inc (CryoLife, Inc.)
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Biosurgery Market Variables, Trends, & Scope
Chapter 4. Biosurgery Market: Product Estimates & Trend Analysis
Chapter 5. Biosurgery Market: Application Estimates & Trend Analysis
Chapter 6. Biosurgery Market: Regional Estimates & Trend Analysis
Chapter 7. Competitive Landscape
Companies Mentioned
The leading players in the Biosurgery market include:- Sanofi
- Baxter
- INTEGRA LIFESCIENCES
- Medtronic
- B. Braun SE
- Pfizer Inc
- Stryker
- Johnson & Johnson Services, Inc
- BD
- Artivion, Inc (CryoLife, Inc.)
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 100 |
| Published | September 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 25.69 Billion |
| Forecasted Market Value ( USD | $ 35.85 Billion |
| Compound Annual Growth Rate | 4.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |
